Okay. everyone. and Thanks, Ari, good morning,
Let's start reviewing revenue. by
base third down XX.X% excluding $X.XXX COVID-related Analytics from the last, of up versus XX.X% business, XX%. Solutions the work all growth for basis revenue $X.X was XXXX. about at revenues were grew In reported was Technology constant reported billion, organic In a X% revenue quarter, and is that COVID-related currency of quarter currency. & quarter million billion quarter our and year constant million, this Third both $XXX at X.X% the constant at currency. third on and approximately $XXX
work, was third COVID-related currency at quarter Solutions constant at of TAS in revenue R&D $X.XXX reported X.X% currency. was all constant billion Excluding organic XX.X% XX%. up and growth
constant Ari work, all R&DS currency was COVID-related at mentioned. XX%, organic Excluding growth in as
basis growth $X.XXX of on X.X% work, that revenue year-to-date. CSMS Finally, constant but revenue all at COVID-related Year-to-date constant Technology currency. billion, Contract CSMS Analytics organic growth about and organic Medical excluding base billion & grew X.X% at reported in and revenue all up X% currency year-to-date reported revenues $XXX constant grew XX.X% X.X% our business, was excluding were at XX%. declined COVID-related Solutions or is constant million reported a currency. third was quarter currency. COVID-related work, was And & currency In at $X.XXX Solutions at constant was X%. million Sales X% $XXX
COVID-related of all growth Solutions in actual constant at work, was currency. $X.XXX work, up organic R&D excluding currency was Solutions and was rates growth Excluding X.X% year-to-date year-to-date. constant Analytics FX billion XX% all at XX%. Tech COVID-related constant R&DS at at & in organic X.X% currency But revenue
revenue or Sales million of at constant X.X% grew Medical and $XXX Contract reported Solutions Finally, CSMS X.X% & currency. year-to-date declined
organic X%. COVID-related was in growth all CSMS currency Excluding work, at constant
third the million for move representing XX.X% year-over-year. let's million EBITDA quarter, Now the was P&L. was Adjusted EBITDA adjusted up $X,XXX year-to-date growth down XX.X% of $XXX while
GAAP Third adjusted diluted grew quarter quarter per $X.XX. and was net share $X.XX year-to-date million million per diluted $XXX per income million GAAP earnings share. the $XXX to and and share for earnings million net per Adjusted income $XXX income or diluted adjusted $X.XX or net share. of net $X.XX was GAAP was earnings XX.X% was income third Year-to-date was $X,XXX
bookings. Now of quarter it's reviewed, already R&D solutions another outstanding delivered
Our backlog at foreign increase impact record X.X% X.X% adjusting exchange. XX basis an a of at September reported a for year-over-year $XX.X stood the and on billion, of
point year-over-year foreign million out of exchange, would might the be that higher. I fact, impact without $XXX In backlog
of X.X% X.X% adjusting month and XX reported billion, exchange. $X.X for to foreign growing a increased revenue backlog year-over-year Next basis impact from the on
now balance $XX,XXX debt resulting and as was Okay, million totalled $XX,XXX September net of gross $X,XXX in reviewing and equivalence of million cash million. cash debt XX, the sheet,
adjusted the leverage month of Our end net was XX the quarter EBITDA. times at X.XX ratio trailing
operations $XXX million cash from $XXX quarter million free result cash $XXX a in for was million CapEx the Third resulting flow flow was strong of and quarter.
our the current that $X.X just It's year-to-date remaining of this program. shares, XXX in repurchased under quarter our under puts leaves saw share billion above slightly we us share the with billion $X.X repurchase. of and million You authorization which repurchase
variable our retired scheduled mature we adjusting our in rates. loans October, you XXXX, early cash strategy to light balance Now, million and interest we're of US of the as higher term of in it dollar rate Earlier discussed so this already in sheet. in this $XXX end September was earlier, month, don't deployment was see
the and pursue We as will repurchase continue additional we term likely XXXX during since shares, while practice our been acquisitions retire to has merger. debt
Now guidance. let's to now turn
last grow November, second quarter headwind to million further since full currency release. to year the dollar the guidance over XXXX, initial For organically revenue work a we includes teens. low-to-mid $XXX continue full reported and the million expect our since our earnings year On basis COVID-related strengthening in a constant at of this has of excluding the impact caused US $XXX
to staff mentioned, conflict visits, wage already as and unresolved able than and the China residual the modest offset our been persisting a inflation, forecasting environment the in in balance shortages, pockets challenges we updated and as them are challenges lockdowns our absorb such of we're and business we've still during all these values. far, addition, so the this patient investigator impact slower global in but numbers, expected of macro continued of reflected recovery in In Russia-Ukraine year,
global by for macro million the guidance, detailed. impact a adjustment midpoint exchange full roughly driven and with be foreign the we represents and $XXX year, of environment to million So the this dollars expect $XX,XXX rest revenue our just I $XX,XXX two-thirds At now of million. the this headwinds an between of by about
year-over-year X.X% this represents low-to-mid growth basis. as at related a a equates on guidance growth X% COVID reported X.X% to work. currency X.X% teens at the constant to currency constant excluding reminder, and updated And organic Our
mention. Our we raising now are represents basis $XX.XX, to and EBITDA growth lastly, reflect the EBITDA range $XX.XX XXX XX%. be year-over-year the guidance end of EBITDA diluted and to now includes to and be from adjusted below reflect And setting which we're XX.X% between contribution -- on be to wins expecting line. by cost We're of the revenue costs $X,XXX the growth guidance We're represents expect estimates guidance updating of EPS adjusted between the projected revenue $X,XXX million of range adjusted between our points growth to to million, approximately adjusted year-over-year our which now EPS also to updated of XX.X%. We XX.X% guidance $X.XX midpoint M&A.
reported currency we of our revenue X.X% or and be expect constant to fourth to X.X% million on basis, on growth guidance, a X.X% X.X% and Moving basis. between a $X,XXX to to quarter $X,XXX million
XX% Excluding fourth to revenue expected to we growing at the be and Adjusted at That's up work, is finally, of be million. expected all is adjusted organic EPS XX.X%. X.X% over COVID-related midpoint and million X.X% expect constant diluted $X.XX between $XXX our currency and guidance. to growth EBITDA between to to be quarter $X.XX $XXX XX.X%
rates Now, as of XX year. all guidance assumes our the for currency October that of of balance foreign the continue
very industry organically operational in we our at healthy. excluding So free before demand Revenue and Q&A, in cash to and summarize quarter. business delivered to go We constant the performance the the underlying work. mid-teens COVID currency strong remained P&L grew flow related
operator in variable fourth first month shares start nearly session. backlog our to Our its we the the RDS our quarter term business continues debt. reducing adjust net strong for the me finally, to $XX.X hand momentum of while that, of excluding trailing with Q&A to of it X.X billion and ratio new exceeding of XX EBITDA ever. approximately With retired leverage Contracted times foreign X%, at over our We up the over $XXX $XXX beginning impact let sits million quarter, the a the bookings the of exchange. repurchase billion time services at $X record million